Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Buy
19,551
+450
+2% +$11.8K 0.35% 70
2026
Q1
$536K Sell
19,101
-1,206
-6% -$32.1K 0.49% 63
2025
Q4
$506K Buy
+20,307
New +$512K 0.49% 70

Other funds holding PFE

PeakShares LLC's PFE Position: Q2 2026 in Review

PeakShares LLC increased its Pfizer (PFE) stake by 2.4% in Q2 2026, buying an estimated $11.8K and bringing the position to 19,551 shares worth $471K. The position accounts for 0.35% of the portfolio, ranked #70.

PeakShares LLC first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $536K in Q1 2026. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • PeakShares LLC held 19,551 shares of Pfizer worth $471K as of Q2 2026.
  • PeakShares LLC bought 450 Pfizer shares in Q2 2026, an estimated $11.8K.
  • Pfizer made up 0.35% of PeakShares LLC's portfolio in Q2 2026, its #70 holding.
  • PeakShares LLC first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • PeakShares LLC's Pfizer position peaked at $536K in Q1 2026.
  • 2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PeakShares LLC's 13F filing for Q2 2026, filed 11 Aug 2026.